vaccine

The Trump administration is weighing a fast-tracked process that would allow AstraZeneca’s coronavirus vaccine to be used in the US before November’s presidential election, a new report says. One plan under consideration would see the Food and Drug Administration issue an “emergency use authorization” for the British drugmaker’s vaccine candidate in October, the Financial Times …

President Donald Trump recently took a monumental step toward permanently plugging gaps in the medical supply chain that became evident during the COVID-19 pandemic. The “Buy American” executive order that he signed will ensure that other nations cannot have the opportunity to deny us life-saving products in a time of need. Medicines and medical supplies …

There are now 53 studies that show positive results of hydroxychloroquine in COVID-19 infections. So, why is the media still spreading misinformation? On July 31, in a column ostensibly dealing with health care “misinformation,” Washington Post media critic Margaret Sullivan opened by lambasting “fringe doctors spouting dangerous falsehoods about hydroxychloroquine as a COVID-19 wonder cure.” …

Top Beijing officials are promising certain countries, with whom they have strategic partnerships, early access to China’s imminent coronavirus vaccines as they seek to repair their global image following criticism over their failure to contain the initial outbreak of the virus. The countries China is working with to produce vaccines and provide early access include …

Shares of German biotechnology firm CureVac nearly tripled in their Nasdaq debut Friday, marking the first stock market debut of a company developing a potential vaccine to combat the novel coronavirus. The stock opened at $44 per share, up from the initial public offering price of $16 per share. CureVac, backed by Microsoft founder and …

Americans likely won’t have to pay for a coronavirus vaccine once researchers have one ready, according to reports. The US government plans to pick up the tab for the hundreds of millions of vaccine doses that pharmaceutical firms are racing to produce, the Wall Street Journal reported. The feds are also reportedly talking with insurance …

The European Commission has placed its first official order for a coronavirus vaccine with a deal to buy 300 million doses of AstraZeneca’s experimental shot, officials said Friday. The body plans to donate vaccines to lower- and middle-income countries through its agreement with the British drugmaker, which gives it the option to buy another 100 …

As Russia claims victory in the race to a successful coronavirus vaccine, scientists are warning against haphazardly adopting the vaccine without testing it sufficiently. Moscow announced Tuesday that Russia has approved a coronavirus vaccine that has proven successful in testing and provides lasting immunity, making Russia the first country to register a vaccine against the pandemic. …

The United States has entered an agreement with drugmaker Moderna Inc to acquire 100 million doses of its potential COVID-19 vaccine for around $1.5 billion, the company and White House said on Tuesday. The United States in recent weeks has made deals to acquire hundreds of millions of doses of potential COVID-19 vaccines from several companies …

Former Food and Drug Administration commissioner Scott Gottlieb sounded a note of caution on Tuesday against Russia’s claim to have produced a vaccine for the coronavirus. Russian president Vladimir Putin announced on Tuesday morning that his country had discovered the first effective treatment for the coronavirus, calling the vaccine “Sputnik V.” However, Gottlieb said that …